Skip to content

Veralox Therapeutics

Site Navigation

  • Team
    • Management Team
    • Advisory Board
    • Board of Directors
  • Technology
  • Investors
  • News
  • Contact Us

News Veralox Therapeutics Appoints Michael Hanna As Chief Medical Officer

June 29 , 2021 Wood Street Company News and Events

Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Michael S. Hanna, MD, FACC, as chief medical officer.

Read more

Share

  • Facebook
  • Twitter
  • Tumblr
  • Pinterest
  • Reddit
  • LinkedIn
  • Email
Previous
Next

Sidebar Navigation

  • Company News and Events

Archive

Search News

Veralox Therapeutics

Footer Navigation

  • Management Team
  • Technology
  • News
  • Contact Us

Follow Us

Copyright 2019 – 2022 Veralox Therapeutics  |  Privacy Policy | Website design by Wood Street, Inc.